ANTIMICROBIAL SUTURE MARKET REPORT OVERVIEW
The global Antimicrobial Suture Market is poised for significant growth, starting at approximately USD 0.33 billion in 2024, climbing to USD 0.37 billion in 2025, and projected to reach USD 0.91 billion by 2033, with a CAGR of about 11.87%.
The antimicrobial suture segment in the medical device field is relatively new because more attention is paid to the prevention of surgical site infections or SSIs along with patients’ outcomes improvement. Tricolson or chlorhexidine coated sutures also termed as antimicrobial sutures are used to minimize bacterial colonization to the wound site as well as to enhance post-surgical healing. These sutures are especially important in operations where there are dangers of accumulation of bacteria that may cause an infection and thus added to aseptic measures.
COVID-19 IMPACT
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The antimicrobial suture market also felt the brunt of COVID-19 because infections abated due to awareness of the healthcare system’s importance and safety. When elective surgeries resumed after the lockdown, patients were back in need of antimicrobial sutures to destroy germs in their bodies, thus increasing demand in the market. Healthcare facilities around the globe increasingly looked towards the integration of new technologies and solutions in order to improve patient care, particularly in increasingly complex surgical procedures to minimize complications.
LATEST TRENDS
Innovative dual-action sutures drive market growth with enhanced healing properties
The current trends being observed in the market include the innovation of better coatings, the integration of biodegradable materials, and the use of two or more potent antimicrobial substances. One emerging trend seen in the industry involves sutures coated with dual-action materials—antimicrobial and anti-inflammatory—which facilitate the healing process as well as prevent infection. This innovation caters to the increasing need for sutures that help in the prevention of SSIs while at the same time enhancing the healing process. The focus on dual-action sutures is rather heavily influencing the overall theme and is becoming one of the primary drivers that set out new trends towards postoperative patient care.
SEGMENTATION
By Type
Based on type the market can be categorized into Triclosan Antimicrobial Suture & Chlorhexidine Antimicrobial Suture.
- Triclosan Antimicrobial Suture: Triclosan antimicrobial sutures are coated with triclosan, which is an Antibacterial agent of broad-spectrum; therefore, the development of SSIs is reduced. For example, monofilaments are functional whereby to regard ordinary bacteria for example, Staphylococcus aureus and Escherichia coli, and post-surgical operations. An increase in the general issues of infections and sterilization together with the increase in the number of surgeries is currently helping in the growth of the triclosan antimicrobial suture market.
- Chlorhexidine antimicrobial suture: Chlorhexidine antimicrobial sutures are coated with chlorhexidine an excellent example of anti-bacterial agents that has long term antibacterial efficacy against several bacterial strains. Such sutures help in decreasing SSIs by allowing a free, constant releasing of chlorhexidine where the surgical incision is intended. Currently, there is a common use of chlorhexidine antimicrobial sutures together with the prospects of chlorhexidine in the elimination of these pathogens are good due to promotion of high health standards precautionary measures which help to avoid surgery related infections.
By Raw Materials
Based on Raw Materials the market can be categorized into Polyglactin 910, Poliglecaprone 25 & Polyglycolic acid.
- Polyglactin 910: Polyglyactin 910 is another Glycolide and Lactide copolymer that is used in antimicrobial sutures mainly since it has the characteristics which makes it strong and has a known rate at which it is absorbed.
- Poliglecaprone 25: Poliglecaprone 25 is a monofilament absorbable suture that provides easy gliding through the tissue and slight tissue inflammation.
- Polyglycolic Acid: Polyglycolic acid (PGA) is a suture material made from ABSORBABLE synthetic fibre which is used in orthopaedic surgery because of its high tensile strength as well as rapid and uniform absorption rate. Non-absorbable antimicrobial PGA sutures are used and for enhanced results often those are coated with agent, chlorhexidine, which contribute to a reduced incidence of post surgical site infection. The market for Polyglycolic Acid antimicrobial sutures is highly promising due to the rather versatile usage of these sutures in various fields of surgery and effectiveness against infection.
DRIVING FACTORS
Growing surgical operations fuel demand, driving market growth
The increase in surgical operations around the world due to the growing geriatric population and the increase in the incidence of diseases are the factors that are driving the Antimicrobial Suture Market Growth. Since more operations are being conducted, the rate of postoperative infections has to be reduced, which in turn leads to a higher demand for antimicrobial sutures. These sutures provide another means of barrier to SSIs, and that is why they are widely used in many fields of surgery. Therefore, an increase in the number of surgeries across the globe will maintain an exact relationship with the growth of the antimicrobial suture market.
Growing awareness of HAIs drives demand, stimulating market growth
Since the ability of identifying the occurrence of the healthcare-associated infections (HAIs) has increased the ascent of demand for the antimicrobial suture in the global market. The heightened concern for HAIs, including SSIs, pertains to the pressures on centers to improve the infection control measures implemented by healthcare institutions, including hospitals. The strategy is relevant here because antimicrobial sutures continuously release antimicrobial substances to the healthy tissues, and the wound site hence reducing contamination. Therefore, the focus on the protection of patient life and planning with the goal of lowering down the infection rate leads to the growing demand for antimicrobial sutures.
RESTRAINING FACTOR
High costs hinder antimicrobial suture adoption, restricting market growth potential
The high costs of antimicrobial sutures in comparison with the traditional ones contribute to restricting factors for consumption growth. Acquiring such processes as these may be expensive, especially for the health care facilities in developing countries. This is because they lack adequate funds as compared to their developed counterparts. Furthermore, the price consciousness in numerous health care systems can slow down the extent of adoption of antimicrobial sutures, even though the evidence shows the positive impacts of their use.
ANTIMICROBIAL SUTURE MARKET REGIONAL INSIGHTS
The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
-
Request a Free sample to learn more about this report.
North America's advanced healthcare and spending drive market growth
North America holds the highest Antimicrobial Suture Market Share owing to its well-developed healthcare sector, higher healthcare spending, and being the first adopter of novel technology products related to medicine. The region receives good legal backing and has a relatively high spend on research and development, which leads to the introduction and acceptance of new and improved surgical products. Besides, increasing the number of surgeries and people’s awareness of infection control also support the magnetic demand for antimicrobial sutures. This, coupled with other factors, makes North America one of the largest markets for and consumers of antimicrobial sutures in the global market.
KEY INDUSTRY PLAYERS
Active players' innovations and strategies drive market growth
Key market players that are currently active in introducing new products in the antimicrobial suture market include mergers and new collaborations. They also engage in research to develop the latest antimicrobial suture technologies that will be demanded by practicing doctors. Moreover, their distribution channels and marketing strategies help them gain market share and extend the usage of antimicrobial sutures in several surgical specialties, hence driving the market.
List of Market Players Profiled
- Johnson & Johnson (Ethicon) (U.S)
- Dolphin Sutures (India)
- Lotus Surgicals (India)
- The Healthium Group (India)
- Internacional Farmacéutica (U.S)
- Meril Life Sciences (India)
- Unilene (U.S)
INDUSTRIAL DEVELOPMENT
May 17, 2024: Ethicon, a big name in medical devices, launched their PDS II+ sutures. These sutures boast sustained antimicrobial activity, which means they can fight germs for a longer duration. This innovation has the potential to be a game-changer by reducing surgical site infections and improving patient outcomes following surgery.
REPORT COVERAGE
This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global Antimicrobial Suture Market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.
This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.
- 26354595
- North America
- 95
Clients
Top Trending
Contact Information
Frequently Asked Questions
-
What value is Antimicrobial Suture Market expected to touch by 2032?
The Antimicrobial Suture Market is expected to reach USD 905.8 million by 2032.
-
What CAGR is the Antimicrobial Suture Market expected to exhibit by 2032?
The Antimicrobial Suture Market is expected to exhibit a CAGR of 11.9% by 2032.
-
Which are the driving factors of the Antimicrobial Suture Market?
Increasing Surgical Procedures & Growing Awareness of Healthcare-Associated Infections (HAIs) are some of the driving factors of the market.
-
What are the key Antimicrobial Suture Market segments?
The key market segmentation that you should be aware of, which include, based on type the Antimicrobial Suture Market is classified as Triclosan Antimicrobial Suture & Chlorhexidine Antimicrobial Suture. Based on Raw Materials Antimicrobial Suture Market is classified as Polyglactin 910, Poliglecaprone 25 & Polyglycolic acid.